STRIDES PHARMA SCIENCE Surges by 6%; BSE HEALTHCARE Index Up 0.4%
May 7, 2020 11:13 AM

STRIDES PHARMA SCIENCE share price has zoomed 6% and is presently trading at Rs 438.

Meanwhile, the BSE HEALTHCARE Index is at 15,350 (up 0.4%).

Among the top Gainers in the BSE HEALTHCARE Index today is STRIDES PHARMA SCIENCE (up 5.8%).

THYROCARE TECHNOLOGIES (down 0.1%) and SANOFI INDIA (down 0.3%) are among the top losers today.

Over the last one year, STRIDES PHARMA SCIENCE has moved down from Rs 457 to Rs 438, registering a loss of Rs 19 (down 4.4%).

On the other hand, the BSE HEALTHCARE has moved up from 14,096 to 15,350, registering a gain of 1,254 points (up 8.0%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 142.2%), J.B.CHEMICALS (up 80.8%) and IPCA LABS (up 64.3%).

What About the Benchmark Indices?

The BSE Sensex is at 31,705 (down 0.8%).

The top gainers among the BSE Sensex stocks today are INDUSIND BANK (up 1.5%), TECH MAHINDRA (up 1.3%) and AXIS BANK (up 1.2%). Other gainers include M&M (up 1.2%) and SUN PHARMA (up 1.0%). The most traded stocks in the BSE Sensex are INDUSIND BANK and AXIS BANK.

In the meantime, NSE Nifty is at 9,278 (down 0.7%). The top gainers in the NSE Nifty include ADANI PORTS & SEZ (up 4.2%), BHARTI INFRATEL (up 3.8%) and INDIABULLS HOU. FIN. (up 2.5%). Other gainers include INDUSIND BANK (up 1.4%) and M&M (up 1.3%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 38,600 to 31,705, registering a loss of 6,895 points (down 18.56%).

STRIDES PHARMA SCIENCE Financial Update...

STRIDES PHARMA SCIENCE net profit stood at Rs 1 billion for the quarter ended December 2019, compared to a profit of Rs 316 million a year ago. Net Sales declined 7.8% to Rs 7.3 billion during the period as against Rs 7.9 billion in October-December 2018.

For the year ended March 2018, STRIDES PHARMA SCIENCE reported 58.6% decrease in net profit to Rs 1.3 billion compared to net profit of Rs 3.2 billion during FY17.

Revenue of the company grew 3.0% to Rs 28 billion during FY18.

The current Price to earnings ratio of STRIDES PHARMA SCIENCE, based on rolling 12 month earnings, stands at 10.3x.